Cortagen vs Livagen — mechanism, half-life, dosing, and research status compared. Which is right for your protocol?
Cortagen (Ala-Glu-Asp-Leu) is a synthetic tetrapeptide from the Khavinson short peptide bioregulator (BCPP) series, specifically designed to target cardiac and vascular tissue. Analogous to Epithalon for the pineal gland and Pinealon for the brain, Cortagen acts as a gene express...
Calculate Cortagen dose →Livagen is a synthetic tetrapeptide (Ala-Glu-Asp-Gly) developed within Vladimir Khavinson's bioregulator peptide program at the Saint Petersburg Institute of Bioregulation and Gerontology. Derived from cardiac tissue, Livagen is designed to target cardiac and cardiovascular gene ...
Calculate Livagen dose →| Parameter | Cortagen | Livagen |
|---|---|---|
| Category | Cardiac & Longevity | Cardiac & Longevity |
| Research | Extensively Studied | Preclinical / Early Human (Russia) |
| Half-Life | ~20–30 min | <1 h |
| Typical Dose | 5–10 mg | 5-10 mcg/day |
| Frequency | Once daily × 10 days (course) | Daily (course-based) |
| Route | Subcutaneous | Subcutaneous, Intranasal |
| FDA Status | Not Approved | Not Approved |
Use ASCEND's free reconstitution calculator to get exact syringe draw amounts for your vial.
For research use only. Not medical advice. ASCEND does not conduct or endorse any specific research protocol. Always consult relevant scientific literature and regulatory guidelines.